Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBT Margin: 2010-2025

Historic EBT Margin for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to 3.29%.

  • Mesa Laboratories' EBT Margin fell 330.00% to 3.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.96%, marking a year-over-year increase of 11929.00%. This contributed to the annual value of 2.47% for FY2025, which is 12998.00% up from last year.
  • Mesa Laboratories' EBT Margin amounted to 3.29% in Q3 2025, which was down 72.05% from 11.78% recorded in Q2 2025.
  • Mesa Laboratories' EBT Margin's 5-year high stood at 12.89% during Q1 2021, with a 5-year trough of -467.42% in Q1 2024.
  • In the last 3 years, Mesa Laboratories' EBT Margin had a median value of 0.74% in 2025 and averaged -40.28%.
  • Per our database at Business Quant, Mesa Laboratories' EBT Margin crashed by 46,693bps in 2024 and then soared by 46,817bps in 2025.
  • Over the past 5 years, Mesa Laboratories' EBT Margin (Quarterly) stood at -4.28% in 2021, then skyrocketed by 781bps to 3.53% in 2022, then climbed by 11bps to 3.64% in 2023, then plummeted by 717bps to -3.53% in 2024, then plummeted by 330bps to 3.29% in 2025.
  • Its EBT Margin stands at 3.29% for Q3 2025, versus 11.78% for Q2 2025 and 0.74% for Q1 2025.